Cargando…
Antiplatelet agents and proton pump inhibitors – personalizing treatment
INTRODUCTION: Antiplatelet therapy remains one of the cornerstones in the management of non-cardioembolic ischemic stroke. However, a significant percentage of patients have concomitant gastroesophageal reflux or peptic ulcer disease that requires acid-reducing medications, the most powerful and eff...
Autores principales: | Lin, Eugene, Padmanabhan, Rajiv, Moonis, Majaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513212/ https://www.ncbi.nlm.nih.gov/pubmed/23226046 |
Ejemplares similares
-
Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
por: Saven, Hannah, et al.
Publicado: (2022) -
Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis
por: Shang, Yao-Sheng, et al.
Publicado: (2022) -
Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset
por: Padma, Srivastava, et al.
Publicado: (2010) -
Editorial: Carotid Revasculatization vs Best Medical Management in Symptomatic Carotid Artery Disease
por: Moonis, Majaz
Publicado: (2018) -
Intracranial Atherosclerosis Disease: A Preventable Epidemic
por: Moonis, Majaz
Publicado: (2020)